查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1786432

全球心血管數位健康市場

Digital Health for Cardiovascular
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球心血管數位健康市場規模將達到1,193億美元

全球心血管數位健康市場規模預計在2024年達到419億美元，預計2024年至2030年期間的複合年成長率為19.1%，到2030年將達到1193億美元。軟體組件是本報告分析的細分市場之一，預計其複合年成長率為17.0%，到分析期結束時規模將達到624億美元。硬體組件細分市場在分析期間內的複合年成長率預計為22.1%。

美國市場規模將達 114 億美元，中國市場預計複合年成長率為 25.5%

美國心血管數位健康市場規模預計在2024年達到114億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到274億美元，在2024-2030年的分析期間內，複合年成長率為25.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為15.4%和16.9%。在歐洲，預計德國市場的複合年成長率約為15.9%。

全球心血管數位健康市場—主要趨勢與促進因素摘要

人工智慧和遠端監控能減輕心血管疾病的負擔嗎？

數位健康解決方案與心血管護理的整合正在重塑心臟相關疾病的管理方式，它利用人工智慧 (AI)、遠端患者監護(RPM) 和穿戴式技術提供對心血管健康的即時洞察。心血管疾病 (CVD) 仍然是全球死亡的主要原因，需要持續監測和早期療育策略。主導的演算法現在可以分析心電圖 (ECG)、檢測心律不整並預測潛在的心臟疾病。智慧型手錶和連網心電圖貼片等遠端監控解決方案使醫生無需頻繁就醫即可追蹤心率變異性、血壓和心律不整。人工智慧虛擬助理的興起透過提供個人化建議、用藥提醒和生活方式調整進一步提高了病人參與。雖然數位心血管解決方案可以加強早期發現和疾病管理，但監管部門核准、資料隱私問題和報銷政策等挑戰仍然是廣泛採用的障礙。然而，隨著人工智慧和遠端監控技術的不斷進步，它們將變得更加主動、數據驅動和可訪問，從而改變心血管護理。

數位療法 (DTx) 如何改善心血管結果？

數位療法 (DTx) 提供基於證據的、軟體主導的干涉措施，補充傳統療法，並正在成為心血管疾病管理的有力工具。與典型的健康應用程式不同，DTx 解決方案經過臨床檢驗，旨在針對特定的心血管風險因素，例如高血壓、高膽固醇和肥胖。 Omada Health 和 Livongo 等公司正在開發基於人工智慧的數位輔導計劃，幫助患者透過行為矯正策略管理與生活方式相關的風險因素。此外，與持續監測設備整合的數位療法可提供即時警報和介入建議，以降低急性心臟事件的風險。向價值導向型醫療保健模式的轉變也促使保險公司承保數位療法，使患者更容易獲得這些解決方案。然而，監管挑戰、醫生的猶豫以及長期臨床檢驗的需求仍然是 DTx 解決方案在心血管護理領域擴展的障礙。隨著研究不斷證明其有效性，數位療法有望成為心血管疾病預防和管理的核心組成部分。

人工智慧和巨量資料將在個人化心血管護理中發揮什麼作用？

人工智慧和巨量資料分析在個人化心血管治療計畫中發揮越來越重要的作用，使基於個人遺傳、代謝和生活方式因素的精準醫療方法成為可能。機器學習模型被用於分析大量資料集，包括電子健康記錄(EHR)、遺傳標記和患者報告數據，以確定心血管患者的個人化治療途徑。人工智慧主導的風險預測模型根據患者罹患心臟病的可能性進行分層，從而實現早期療育和有針對性的預防措施。此外，人工智慧聊天機器人和遠端醫療平台透過提供客製化建議和即時回答心血管健康諮詢來提高病人參與。儘管人工智慧潛力巨大，但要充分發揮其在心血管醫療保健領域的潛力，需要解決人工智慧模型偏見、數據互通性問題以及監管部門核准需求等挑戰。然而，隨著巨量資料不斷完善精準醫療方法，人工智慧有望在最佳化心血管治療結果方面發揮重要作用。

是什麼推動了心血管數位健康市場的成長？

心血管數位健康市場的成長受到多種因素的推動，包括心臟病患病率的上升、穿戴式醫療技術的普及以及主導診斷技術的進步。全球向遠端醫療服務的轉變推動了遠端患者監護和家庭心臟護理的需求激增。監管機構也認知到數位健康介入的重要性，從而增加了對數位心血管解決方案的核准和報銷支持。區塊鏈與網路安全措施的整合正在加強病患資料的安全性，並提升人們對數位健康平台的信任。此外，精準醫療和個人化治療方法的興起，正推動醫療服務提供者在心血管護理領域採用人工智慧驅動的預測分析技術。對數位健康新興企業的持續投資，以及科技公司、醫療服務提供者和保險公司之間的策略聯盟，將推動數位心血管健康市場的顯著成長，重塑心臟病管理的未來。

部分

組件（軟體組件、硬體組件、服務組件）；最終用途（患者、提供者、付款人、其他）

受訪公司範例

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP30497

Global Digital Health for Cardiovascular Market to Reach US$119.3 Billion by 2030

The global market for Digital Health for Cardiovascular estimated at US$41.9 Billion in the year 2024, is expected to reach US$119.3 Billion by 2030, growing at a CAGR of 19.1% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$62.4 Billion by the end of the analysis period. Growth in the Hardware Component segment is estimated at 22.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.4 Billion While China is Forecast to Grow at 25.5% CAGR

The Digital Health for Cardiovascular market in the U.S. is estimated at US$11.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.4 Billion by the year 2030 trailing a CAGR of 25.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 16.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.9% CAGR.

Global Digital Health for Cardiovascular Market - Key Trends & Drivers Summarized

Can AI and Remote Monitoring Reduce Cardiovascular Disease Burden?

The integration of digital health solutions in cardiovascular care is reshaping how heart-related diseases are managed, leveraging artificial intelligence (AI), remote patient monitoring (RPM), and wearable technologies to provide real-time insights into cardiovascular health. Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous monitoring and early intervention strategies. AI-driven algorithms are now capable of analyzing electrocardiograms (ECGs), detecting arrhythmias, and predicting potential cardiac events before they occur. Remote monitoring solutions, such as smartwatches and connected ECG patches, allow physicians to track heart rate variability, blood pressure, and irregular heart rhythms without requiring patients to visit hospitals frequently. The rise of AI-powered virtual health assistants is further improving patient engagement by offering personalized recommendations, medication reminders, and lifestyle modifications. While digital cardiovascular solutions enhance early detection and disease management, challenges such as regulatory approval, data privacy concerns, and reimbursement policies remain barriers to widespread adoption. However, as AI and remote monitoring technologies continue to improve, they are poised to transform cardiovascular care by making it more proactive, data-driven, and accessible.

How Are Digital Therapeutics (DTx) Improving Cardiovascular Outcomes?

Digital therapeutics (DTx) are emerging as a powerful tool in cardiovascular disease management, offering evidence-based, software-driven interventions to complement traditional treatments. Unlike general wellness apps, DTx solutions are clinically validated and designed to target specific cardiovascular risk factors such as hypertension, high cholesterol, and obesity. Companies like Omada Health and Livongo are developing AI-powered digital coaching programs that help patients manage lifestyle-related risk factors through behavior modification strategies. Furthermore, digital therapeutics integrated with continuous monitoring devices provide real-time alerts and intervention recommendations, reducing the risk of acute cardiac events. The shift toward value-based healthcare models is also driving insurance providers to cover digital therapeutics, making these solutions more accessible to patients. However, regulatory challenges, physician adoption hesitancy, and the need for long-term clinical validation remain obstacles to scaling DTx solutions in cardiovascular health. As research continues to demonstrate their effectiveness, digital therapeutics are expected to become a core component of cardiovascular disease prevention and management.

What Role Do AI and Big Data Play in Personalized Cardiovascular Care?

AI and big data analytics are playing an increasingly critical role in personalizing cardiovascular treatment plans, allowing for precision medicine approaches based on an individual's genetic, metabolic, and lifestyle factors. Machine learning models are being used to analyze vast datasets, including electronic health records (EHRs), genetic markers, and patient-reported data, to identify personalized treatment pathways for cardiovascular patients. AI-driven risk prediction models can stratify patients based on their likelihood of developing heart disease, enabling early intervention and targeted preventive measures. Additionally, AI-powered chatbots and telehealth platforms are improving patient engagement by providing tailored recommendations and answering cardiovascular health queries in real time. Despite the immense potential, challenges such as bias in AI models, data interoperability issues, and the need for regulatory approvals must be addressed to unlock the full capabilities of AI in cardiovascular healthcare. However, as big data continues to refine precision medicine approaches, AI is expected to play an indispensable role in optimizing cardiovascular treatment outcomes.

What Is Driving the Growth of the Digital Health for Cardiovascular Market?

The growth in the digital health for cardiovascular market is driven by several factors, including the increasing prevalence of heart diseases, rising adoption of wearable health technologies, and advancements in AI-driven diagnostics. The demand for remote patient monitoring and home-based cardiac care is surging due to the global shift toward telehealth services. Regulatory bodies are also recognizing the importance of digital health interventions, leading to increased approvals and reimbursement support for digital cardiovascular solutions. The integration of blockchain and cybersecurity measures is enhancing patient data security, increasing trust in digital health platforms. Additionally, the rise of precision medicine and personalized treatment approaches is pushing healthcare providers toward AI-powered predictive analytics in cardiovascular care. With continued investment in digital health startups and strategic partnerships among tech companies, healthcare providers, and insurers, the digital cardiovascular health market is set to experience significant growth, reshaping the future of heart disease management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Cardiovascular market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software Component, Hardware Component, Service Component); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AliveCor
  • Amwell
  • Cardiogram
  • CardioSignal
  • Cardiovascular Health Solutions
  • Cleerly
  • DarioHealth
  • Eko
  • Fitbit
  • HeartFlow
  • Hello Heart
  • Idoven
  • Lark Health
  • Medtronic
  • Omron Healthcare
  • Philips Healthcare
  • Withings
  • Neko Health
  • Story Health
  • WellDoc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Digital Health for Cardiovascular - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Drives Demand for Digital Health Solutions in Cardiovascular Care
    • Surge in Remote Patient Monitoring and Telemedicine Adoption Expands Addressable Market for Cardiovascular Digital Health Technologies
    • Technological Advancements in Wearable Devices and Health Monitoring Tools Strengthen the Business Case for Digital Health in Cardiovascular Care
    • Growing Consumer Awareness of Heart Health Accelerates Adoption of Digital Health Solutions for Cardiovascular Disease Prevention
    • Rising Healthcare Costs and Need for Efficient Treatment Models Propel Demand for Digital Health Solutions in Cardiovascular Disease Management
    • Integration of Artificial Intelligence and Machine Learning in Cardiovascular Digital Health Tools Enhances Diagnosis and Treatment Planning
    • Increased Focus on Personalized Healthcare and Precision Medicine Drives Growth in Digital Health Solutions Tailored for Cardiovascular Patients
    • Expansion of Mobile Health Applications and Smartphone Integration Strengthens the Market for Cardiovascular Health Management Tools
    • The Proliferation of Big Data and Predictive Analytics in Cardiovascular Care Accelerates Adoption of Digital Health Platforms for Early Diagnosis
    • Surge in Investment by Governments and Healthcare Providers in Digital Health Infrastructure Drives Market Growth
    • The Integration of IoT in Cardiovascular Health Devices Enables Real-Time Data Collection, Expanding Market Opportunities
    • Regulatory Support for Digital Health Solutions and Remote Monitoring Devices Strengthens Market Confidence and Adoption
    • The Shift Toward Preventative Healthcare and Early Detection Strengthens Demand for Digital Health Solutions in Cardiovascular Care
    • Increasing Need for Chronic Disease Management Solutions Drives Growth in Digital Health Platforms for Long-Term Cardiovascular Care
    • Expansion of Healthcare Networks and Telehealth Programs Creates Opportunities for Cardiovascular Digital Health Solutions in Rural and Underserved Areas
    • The Growth of Cloud Computing and Data Storage Solutions in Healthcare Expands the Scalability and Reach of Digital Health Tools for Cardiovascular Care
    • The Rising Popularity of Fitness and Wellness Tracking Devices Drives Demand for Digital Health Solutions in Cardiovascular Health Management
    • Rising Incidence of Cardiovascular Disease in Aging Populations Expands the Addressable Market for Digital Cardiovascular Health Solutions
    • Regulatory Advances in Digital Health Technologies Create New Opportunities for Compliance-Driven Cardiovascular Health Solutions
    • Increased Focus on Patient Engagement and Empowerment Drives Adoption of Digital Health Tools for Cardiovascular Disease Prevention and Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Health for Cardiovascular Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Health for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Service Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Service Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patients End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patients End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Digital Health for Cardiovascular by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Digital Health for Cardiovascular by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Digital Health for Cardiovascular by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Digital Health for Cardiovascular Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Digital Health for Cardiovascular by Component - Software Component, Hardware Component and Service Component Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Digital Health for Cardiovascular by Component - Percentage Breakdown of Value Sales for Software Component, Hardware Component and Service Component for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Digital Health for Cardiovascular by End-Use - Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Digital Health for Cardiovascular by End-Use - Percentage Breakdown of Value Sales for Patients End-Use, Providers End-Use, Payers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION